The Role of Enzymology in a Structure-Based Drug Discovery Program: Bacterial DNA Gyrase — Mark L. Cunningham

The capability to accurately, rapidly, and reproducibly determine the affinity of a ligand for a target protein or enzyme is a vital component for a successful structure-based drug design effort.

Type:: Book Chapter
Author:: Mark L. Cunningham
Published:: 2011
Publisher:: Humana Press

The capability to accurately, rapidly, and reproducibly determine the affinity of a ligand for a target protein or enzyme is a vital component for a successful structure-based drug design effort. In order to successfully drive a structure-based drug design (SBDD) project forward, multiple distinct assays, each with particular strengths and weaknesses, need to be employed. Using bacterial DNA gyrase as an example, a range of assays are described that will fully support an SBDD program.

Get this book

Amazon (ABD) Amazon TR

ⓘ These are affiliate links; if you make a purchase, we may earn a commission at no extra cost to you.

Türkçe sayfa →

Sıkça sorulan sorular

What is "The Role of Enzymology in a Structure-Based Drug Discovery Program: Bacterial DNA Gyrase" about?: The capability to accurately, rapidly, and reproducibly determine the affinity of a ligand for a target protein or enzyme is a vital component for a successful structure-based drug design effort.
Who wrote "The Role of Enzymology in a Structure-Based Drug Discovery Program: Bacterial DNA Gyrase"?: Mark L. Cunningham